ARTICLE SUMMARY:
An interview with Pamela Goldberg, head of MDIC, whose goal is to bring together all of the major medtech stakeholders—public and private—to address many of the key issues the industry faces. The result is an agenda as broad as its membership, ranging from regulatory science and real-world evidence to reimbursement issues and cybersecurity.
In a perfect world, the process for developing and commercializing a medical device would involve a range of contributors with the variety of necessary skills all pulling together to deliver innovative technology to the market. The reality, as we all know, is quite a different story.
